Caribou Biosciences Statistics
Total Valuation
CRBU has a market cap or net worth of $144.51 million. The enterprise value is -$122.32 million.
| Market Cap | 144.51M |
| Enterprise Value | -122.32M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CRBU has 90.32 million shares outstanding. The number of shares has increased by 45.95% in one year.
| Shares Outstanding | 90.32M |
| Shares Change (YoY) | +45.95% |
| Shares Change (QoQ) | +20.99% |
| Owned by Insiders (%) | 10.06% |
| Owned by Institutions (%) | 76.98% |
| Float | 69.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.33 |
| Forward PS | 10.42 |
| PB Ratio | 0.42 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.49, with a Debt / Equity ratio of 0.08.
| Current Ratio | 10.49 |
| Quick Ratio | 10.22 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -33.40% and return on invested capital (ROIC) is -35.35%.
| Return on Equity (ROE) | -33.40% |
| Return on Assets (ROA) | -28.00% |
| Return on Capital (ROIC) | -35.35% |
| Revenue Per Employee | $211,418 |
| Profits Per Employee | -$729,494 |
| Employee Count | 158 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CRBU has paid $193,000 in taxes.
| Income Tax | 193,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.78% in the last 52 weeks. The beta is 2.43, so CRBU's price volatility has been higher than the market average.
| Beta (5Y) | 2.43 |
| 52-Week Price Change | -60.78% |
| 50-Day Moving Average | 2.79 |
| 200-Day Moving Average | 4.74 |
| Relative Strength Index (RSI) | 25.87 |
| Average Volume (20 Days) | 2,975,630 |
Short Selling Information
The latest short interest is 12.27 million, so 13.59% of the outstanding shares have been sold short.
| Short Interest | 12.27M |
| Short Previous Month | 11.51M |
| Short % of Shares Out | 13.59% |
| Short % of Float | 17.78% |
| Short Ratio (days to cover) | 4.04 |
Income Statement
In the last 12 months, CRBU had revenue of $33.40 million and -$115.26 million in losses. Loss per share was -$1.46.
| Revenue | 33.40M |
| Gross Profit | 33.40M |
| Operating Income | -130.95M |
| Pretax Income | -115.07M |
| Net Income | -115.26M |
| EBITDA | -109.36M |
| EBIT | -115.07M |
| Loss Per Share | -$1.46 |
Balance Sheet
The company has $293.99 million in cash and $27.16 million in debt, giving a net cash position of $266.83 million or $2.95 per share.
| Cash & Cash Equivalents | 293.99M |
| Total Debt | 27.16M |
| Net Cash | 266.83M |
| Net Cash Per Share | $2.95 |
| Equity (Book Value) | 343.29M |
| Book Value Per Share | 3.80 |
| Working Capital | 275.49M |
Cash Flow
In the last 12 months, operating cash flow was -$102.56 million and capital expenditures -$11.03 million, giving a free cash flow of -$113.59 million.
| Operating Cash Flow | -102.56M |
| Capital Expenditures | -11.03M |
| Free Cash Flow | -113.59M |
| FCF Per Share | -$1.27 |
Margins
Gross margin is 100.00%, with operating and profit margins of -392.00% and -345.05%.
| Gross Margin | 100.00% |
| Operating Margin | -392.00% |
| Pretax Margin | -344.47% |
| Profit Margin | -345.05% |
| EBITDA Margin | -327.40% |
| EBIT Margin | -344.47% |
| FCF Margin | -340.03% |
Dividends & Yields
CRBU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -45.95% |
| Shareholder Yield | -45.95% |
| Earnings Yield | -79.76% |
| FCF Yield | -78.60% |
Analyst Forecast
The average price target for CRBU is $15.67, which is 879.38% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.67 |
| Price Target Difference | 879.38% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 61.96% |
| EPS Growth Forecast (5Y) | -11.61% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CRBU has an Altman Z-Score of 0.15 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.15 |
| Piotroski F-Score | 4 |